Is Novo Nordisk Stock a Buy Now?
Weight-loss drugs are the health craze of 2023. According to the management of , America's largest retailer, drugs like Ozempic and Wegovy have begun impacting food sales.
Perhaps it shouldn't be surprising that shares of Novo Nordisk (NYSE: NVO), the pharmaceutical company behind Ozempic and Wegovy, have done well. The stock is up 36% since January and more than 70% over the past twelve months.
So, is it too late to enjoy this potentially monumental shift in the healthcare landscape? Or is Novo Nordisk's fortune a fad, like many previous health trends? Here's what you need to know.
Source Fool.com
Walmart Inc. Aktie
72,33 €
0,49 %
Mit 92 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung ist Walmart Inc. einer der Lieblinge unserere Community.
Das Kursziel von 74 € für Walmart Inc. weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 72.33 € hin.
